Skip to content
Elite Vision Online

The Zimbabwean Government Rejects ‘One-Sided’ American Health Aid Package Because of Information Concerns

Medical aid image
The offered US funding was intended for initiatives for treating and preventing HIV/Aids, tuberculosis, and malarial diseases.

Zimbabwe has turned down a major US health deal valued at 367 million US dollars (£272m) over five years because of the United States' request for sensitive information.

The decision became public after a government memo from December was disclosed, indicating that Head of State Emmerson Mnangagwa felt the agreement was "unbalanced".

An official representative later clarified that the United States was demanding access to health data for scientific study and commercial gain but was not willing to guarantee the resulting advantages from future vaccines.

"We must now begin the difficult and regrettable task of winding down our support in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.

Her embassy said the United States had donated more than $1.9bn as health assistance to Zimbabwe over the last twenty years.

A physicians' group in Zimbabwe has appealed for continued dialogue to secure a deal acceptable to all parties so the country's critical HIV treatment initiative can continue.

Broader Background

This development follows a similar case in neighbouring Kenya, where a court halted a related deal with the US following concerns were filed about the safety of Kenyans' health data.

After resuming the presidency last year, US President Donald Trump has reduced foreign aid and closed the key foreign aid agency.

The agency had administered assistance for the American government, but Trump argued its expenditure was "wasteful" and his administration was seeking government-to-government deals to boost openness and responsibility.

Based on reports, Sixteen nations in Africa have to date agreed to these new health pacts, representing over $18.3bn in new funding.

Specifics of the Declined Deal

This assistance for Zimbabwe was intended to gone towards "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and preparing for epidemics".

"We believe this partnership would have delivered extraordinary benefits for the people of Zimbabwe, especially the 1.2 million currently on HIV treatment via American-funded initiatives," the Ambassador commented.

However, government spokesperson Nick Mangwana maintained the arrangement was "unequal".

"Zimbabwe was being asked to share its biological resources and data over an extended period, with no corresponding assurance of access to any scientific breakthroughs – like vaccines, diagnostics, or treatments – that might result from that provided information," he stated.

"Effectively, our country would supply the basic resources for scientific discovery with no certainty that the final treatments would be accessible to our citizens should a future health crisis arise."

Sovereignty and International Frameworks

He also noted that the American exit from the global health body and its push of one-on-one health agreements were undermining structures previously established via the global organization.

Mangwana gave as an example its Pandemic Benefit-Sharing system designed to manage future pandemics.

"This mechanism is intended to ensure that when a nation provides its samples, the benefits – including medicines and cures – are distributed fairly, not commercialised solely by those with the funds to develop them."

Zimbabwe's reservations over the US deal "are not meant as opposition to America," he added.

"We encourage continued dialogue with our American counterparts on how subsequent co-operation could be designed in a way that respects the independence and interests of each country."

Health Experts Response

Medical experts expressed it acknowledged the official position, but recommended that talks need to persist considering much of the nation's HIV programmes depended on external financing.

"Where technical issues arise, such as those involving information security or implementation frameworks, these can often be addressed through technical clarification and negotiated safeguards," the group said.

The situation underscores the continuing debate between accepting crucial foreign assistance and protecting local interests in an ever more data-driven world.

The writer

Audrey Paul

Lena Visser is een ervaren optometrist met een passie voor het verbeteren van het zicht van mensen met visuele beperkingen.

Elite Vision Online

Type to search articles.